Drug company expands voluntary recall of infant ibuprofen
MONMOUTH JUNCTION, N.J. (AP) — Tris Pharma has expanded its voluntary recall of infant ibuprofen because it may contain overly high concentrations of the drug.
The company, based in Monmouth Junction, New Jersey, announced the move this week.
It says the concentration can be as high as 10 percent above the specified limit. The affected brands include CVS health and Equate and are sold at Walmart, CVS and Family Dollar stores.
Infants already susceptible to the adverse effects of ibuprofen could be at a slightly higher risk if given medication from a recalled bottle. There’s a remote possibility an elevated level of ibuprofen could lead to permanent kidney damage in babies.
Other potential adverse health effects include nausea, vomiting, stomach pain and diarrhea.
Tris Pharma says it hasn’t received any reports of related health problems.
The Western Journal has not reviewed this Associated Press story prior to publication. Therefore, it may contain editorial bias or may in some other way not meet our normal editorial standards. It is provided to our readers as a service from The Western Journal.
Truth and Accuracy
We are committed to truth and accuracy in all of our journalism. Read our editorial standards.
